|
|
Article: Princeton obtains United States patent.
- Article from:
- BIOTECH Patent News
- Article date:
- October 1, 2005
CopyrightCOPYRIGHT 2005 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Princeton University (Princeton, NJ) has patented isolated mammalian nucleic acid molecules encoding receptor protein tyrosine kinases expressed in primitive hematopoietic cells and not expressed in mature hematopoietic cells. Also included are the receptors encoded by such nucleic acid molecules; the nucleic acid molecules encoding receptor protein tyrosine kinases having the sequences shown in FIG. 1a (murine flk-2), FIG. 1b (human flk-2) and FIG. 2 (murine flk-1); the receptor protein ...
Related newspaper, magazine, and journal articles:
|
|
Article: Cytokine Engraftment for Protein Delivery to Hematopoietic ...
Gene Therapy Weekly;
February 1, 1999 ;
700+ words
... ... methods for direct gene transfer into hematopoietic cells are inefficient, noted Hagop Youssoufian ... for functional complementation of hematopoietic cells using cell culture models of FA ... to introduce the FAC protein into hematopoietic cells by exploiting the interaction of ...
|
|